Skip to main content
. 2019 Oct 22;2019(10):CD005015. doi: 10.1002/14651858.CD005015.pub4

Jorge 2016.

Methods

  • Study design: parallel RCT

  • Study duration: not reported

  • Duration of follow‐up: 30 months
Participants

  • Country: Portugal

  • Setting: not reported

  • Inclusion criteria: kidney transplant recipients

  • Number: treatment group (73); control group (68)

  • Mean age (years): treatment group (51); control group (52)

  • Sex (M): treatment group (57.4%); control group (56.2%)

  • Exclusion criteria: not reported
Interventions Treatment group

  • Cholecalciferol: 4000 IU/d


Control group

  • No treatment


Co‐interventions

  • Antihypertensives, active vitamin D or cinacalcet
Outcomes

  • iPTH

  • eGFR

  • CRP

  • Serum calcium, phosphate, magnesium
Notes

  • Abstract‐only publication

  • Data cannot be meta‐analysed